Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017

Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status betwee...

Full description

Saved in:
Bibliographic Details
Published inJournal of hematology and oncology Vol. 12; no. 1; pp. 140 - 12
Main Authors Li, Na, Deng, Yujiao, Zhou, Linghui, Tian, Tian, Yang, Si, Wu, Ying, Zheng, Yi, Zhai, Zhen, Hao, Qian, Song, Dingli, Zhang, Dai, Kang, Huafeng, Dai, Zhijun
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 21.12.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries.
AbstractList Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. Methods We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. Results In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. Conclusion The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries. Keywords: Breast cancer, Global cancer burden, Disability-adjusted life years, Alcohol use, Incidence
Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries.
Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017.BACKGROUNDStatistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017.We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study.METHODSWe extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study.In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose.RESULTSIn 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose.The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries.CONCLUSIONThe increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries.
Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries.
Abstract Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. Methods We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. Results In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. Conclusion The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries.
Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate breast cancer incidence, deaths, and disability-adjusted life years (DALYs) by country, gender, age group, and social-demographic status between 1990 and 2017. Methods We extracted breast cancer data from the 2017 Global Burden of Disease (GBD) study from 1990 through 2017 in 195 countries and territories. Data about the number of breast cancer incident cases, deaths, DALYs, and the age-standardized rates were collected. We also estimated the risk factors attributable to breast cancer deaths and DALYs using the comparative risk assessment framework of the GBD study. Results In 2017, the global incidence of breast cancer increased to 1,960,681 cases. The high social-development index (SDI) quintile included the highest number of breast cancer death cases. Between 2007 and 2017, the ASDR of breast cancer declined globally, especially in high SDI and high middle SDI countries. The related DALYs were 17,708,600 in 2017 with high middle SDI quintile as the highest contributor. Of the deaths and DALYs, alcohol use was the greatest contributor in most GBD regions and other contributors included high body mass index (BMI) and high fasting plasma glucose. Conclusion The increasing global breast cancer burden is mainly observed in lower SDI countries; in higher SDI countries, the breast cancer burden tends to be relieving. Therefore, steps against attributable risk factors should be taken to reduce breast cancer burden in lower SDI countries.
ArticleNumber 140
Audience Academic
Author Zhai, Zhen
Zheng, Yi
Li, Na
Deng, Yujiao
Hao, Qian
Yang, Si
Zhang, Dai
Tian, Tian
Kang, Huafeng
Dai, Zhijun
Wu, Ying
Zhou, Linghui
Song, Dingli
Author_xml – sequence: 1
  givenname: Na
  surname: Li
  fullname: Li, Na
– sequence: 2
  givenname: Yujiao
  surname: Deng
  fullname: Deng, Yujiao
– sequence: 3
  givenname: Linghui
  surname: Zhou
  fullname: Zhou, Linghui
– sequence: 4
  givenname: Tian
  surname: Tian
  fullname: Tian, Tian
– sequence: 5
  givenname: Si
  surname: Yang
  fullname: Yang, Si
– sequence: 6
  givenname: Ying
  surname: Wu
  fullname: Wu, Ying
– sequence: 7
  givenname: Yi
  surname: Zheng
  fullname: Zheng, Yi
– sequence: 8
  givenname: Zhen
  surname: Zhai
  fullname: Zhai, Zhen
– sequence: 9
  givenname: Qian
  surname: Hao
  fullname: Hao, Qian
– sequence: 10
  givenname: Dingli
  surname: Song
  fullname: Song, Dingli
– sequence: 11
  givenname: Dai
  surname: Zhang
  fullname: Zhang, Dai
– sequence: 12
  givenname: Huafeng
  surname: Kang
  fullname: Kang, Huafeng
– sequence: 13
  givenname: Zhijun
  orcidid: 0000-0001-5209-8626
  surname: Dai
  fullname: Dai, Zhijun
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31864424$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1u1DAUhSNURNuBB2CDLCEhFqTYjmPHLJBKgVKpEgtgbdnO9YxLJm5tB6kvxHPi-WmZqUBZOPb9zvHNzTmuDsYwQlU9J_iEkI6_TaTBrK0xkTXuaFfjR9URES2vO0Hpwc77YXWc0hXGnEiKn1SHTVEzRtlR9ft8CEYPyEyxhxEFh0wEnTKyerQQkR57pHOO3kxZmwFQ9OknctrmEBPyIyKyRTZMY0EgrfEMMfpSLvs3yMWwLIzEKAdEMRHvUIQ0DTltSnkBaNvCh_sWPvpUegD0LU_97Vr1tHrs9JDg2XadVT8-f_p-9qW-_Hp-cXZ6WdtWklxz2xECxvXclFUaLo3DopOibcA5YwUF1wrRi54B7UjZEgnSdSBFwzSDZlZdbHz7oK_UdfRLHW9V0F6tD0KcKx2ztwMoLbXoNGl7IYBZy3XHuQHQjLSmY5YWr_cbr-vJLKG3UGakhz3T_croF2oefikuactKR7Pq9dYghpsJUlZLnywMgx4hTEnRpim_lGLJC_ryAXoVpjiWURWKYcEx79hfaq7LB_jRhXKvXZmqU05wQxkTTaFO_kGVp4eltyWBzpfzPcGrHcEC9JAXKQxT9mFM--CL3Yncj-IujgUQG8DGkFIEp6zPeuVTWvCDIlitgq82wVcl-GoVfIWLkjxQ3pn_X_MHo1oCkA
CitedBy_id crossref_primary_10_1177_10732748251328413
crossref_primary_10_1038_s41598_024_54762_x
crossref_primary_10_4274_balkanmedj_galenos_2024_2024_4_91
crossref_primary_10_4103_abr_abr_200_22
crossref_primary_10_3389_fmolb_2022_856064
crossref_primary_10_1186_s12885_021_08217_5
crossref_primary_10_1186_s40364_021_00310_y
crossref_primary_10_3389_fonc_2022_836126
crossref_primary_10_1002_jcla_23720
crossref_primary_10_1134_S0026893321020163
crossref_primary_10_1136_bmjopen_2022_071306
crossref_primary_10_1038_s41598_021_87209_8
crossref_primary_10_1038_s41598_024_61600_7
crossref_primary_10_1186_s13045_020_00908_z
crossref_primary_10_3389_fonc_2022_853038
crossref_primary_10_3389_fmolb_2021_675198
crossref_primary_10_1016_j_intimp_2020_106756
crossref_primary_10_1186_s13058_023_01609_4
crossref_primary_10_1007_s00520_021_06692_x
crossref_primary_10_2147_IJGM_S447201
crossref_primary_10_1186_s12935_023_02860_7
crossref_primary_10_1186_s13045_020_00981_4
crossref_primary_10_1186_s13045_021_01052_y
crossref_primary_10_1080_07853890_2024_2314235
crossref_primary_10_1097_CM9_0000000000001814
crossref_primary_10_3390_molecules28124876
crossref_primary_10_1111_ahg_12415
crossref_primary_10_2147_CLEP_S388323
crossref_primary_10_1016_j_jare_2022_10_007
crossref_primary_10_3389_fonc_2022_1010088
crossref_primary_10_18632_aging_202415
crossref_primary_10_3390_cancers12092419
crossref_primary_10_1016_j_eclinm_2024_102713
crossref_primary_10_1136_bmjopen_2022_066505
crossref_primary_10_1186_s12885_023_10962_8
crossref_primary_10_1016_j_maturitas_2021_06_008
crossref_primary_10_18632_aging_203187
crossref_primary_10_2147_CMAR_S274204
crossref_primary_10_1002_cam4_3305
crossref_primary_10_1186_s12889_023_17405_w
crossref_primary_10_1016_j_biopha_2020_111139
crossref_primary_10_1002_jmv_28768
crossref_primary_10_3389_fnut_2022_817836
crossref_primary_10_3390_ijerph20010840
crossref_primary_10_1002_cam4_5166
crossref_primary_10_1007_s12282_021_01267_4
crossref_primary_10_1186_s40164_020_00181_3
crossref_primary_10_20892_j_issn_2095_3941_2022_0231
crossref_primary_10_1007_s11356_022_24410_w
crossref_primary_10_2147_IJGM_S319801
crossref_primary_10_3390_ijerph191610068
crossref_primary_10_3389_fnut_2022_847920
crossref_primary_10_1038_s41598_024_84115_7
crossref_primary_10_1007_s10549_020_05736_w
crossref_primary_10_18857_jkpt_2020_32_3_176
crossref_primary_10_3389_fpubh_2022_1078191
crossref_primary_10_1038_s41597_023_02253_5
crossref_primary_10_1016_j_prp_2020_153131
crossref_primary_10_1186_s12885_024_12796_4
crossref_primary_10_24018_ejbiomed_2022_1_4_20
crossref_primary_10_1039_D0DT00507J
crossref_primary_10_1002_ctm2_400
crossref_primary_10_3389_fpubh_2024_1371253
crossref_primary_10_1016_j_semcancer_2020_08_009
crossref_primary_10_1136_bmjopen_2021_052676
crossref_primary_10_1016_j_clbc_2023_04_009
crossref_primary_10_1186_s13058_023_01633_4
crossref_primary_10_3390_metabo12040350
crossref_primary_10_1017_S1368980022001987
crossref_primary_10_3390_ijms24021168
crossref_primary_10_1093_jnci_djad101
crossref_primary_10_1016_j_jare_2021_07_012
crossref_primary_10_2147_CMAR_S280009
crossref_primary_10_3390_nu16060800
crossref_primary_10_1093_pubmed_fdaa099
crossref_primary_10_1016_j_clon_2022_05_007
crossref_primary_10_1097_CM9_0000000000001347
crossref_primary_10_3390_nu12020512
crossref_primary_10_1186_s12964_024_01487_z
crossref_primary_10_1002_jcla_24186
crossref_primary_10_3389_fonc_2020_01245
crossref_primary_10_3389_fonc_2022_998641
crossref_primary_10_1097_CEJ_0000000000000909
crossref_primary_10_1111_cbdd_14222
crossref_primary_10_2147_JIR_S376248
crossref_primary_10_1038_s41523_021_00293_x
crossref_primary_10_1007_s00432_025_06113_0
crossref_primary_10_1007_s10528_021_10029_y
crossref_primary_10_1038_s41388_020_01574_8
crossref_primary_10_51847_KBUc8DsiTj
crossref_primary_10_1007_s00432_023_05380_z
crossref_primary_10_1186_s13053_020_00159_6
crossref_primary_10_3389_fonc_2022_905846
crossref_primary_10_1080_2162402X_2020_1859731
crossref_primary_10_1002_iub_2764
crossref_primary_10_1007_s12553_021_00592_0
crossref_primary_10_1111_papr_13009
crossref_primary_10_1186_s12982_025_00491_z
crossref_primary_10_1002_cam4_5006
crossref_primary_10_1186_s12916_023_02950_3
crossref_primary_10_1016_j_imu_2022_101009
crossref_primary_10_2196_49197
crossref_primary_10_1136_bmjopen_2020_044283
crossref_primary_10_1002_jgm_3271
crossref_primary_10_1186_s13000_022_01249_w
crossref_primary_10_1016_j_prp_2020_153117
crossref_primary_10_1093_ehjqcco_qcae049
crossref_primary_10_18632_aging_202502
crossref_primary_10_1016_j_bioorg_2021_105017
crossref_primary_10_1177_15347354221104092
crossref_primary_10_46234_ccdcw2023_065
crossref_primary_10_3389_fonc_2021_642768
crossref_primary_10_4103_cjop_CJOP_D_22_00165
crossref_primary_10_1016_j_eclinm_2021_100986
crossref_primary_10_1186_s12889_024_19934_4
crossref_primary_10_18632_aging_103881
crossref_primary_10_3389_fonc_2021_689562
crossref_primary_10_1016_j_jcjd_2023_12_007
crossref_primary_10_2147_IJN_S460712
crossref_primary_10_1039_D3FO04279K
crossref_primary_10_1186_s13045_021_01213_z
crossref_primary_10_1002_gcc_23150
crossref_primary_10_1007_s12262_020_02388_4
crossref_primary_10_1016_j_heliyon_2024_e33639
crossref_primary_10_2147_IJN_S321071
crossref_primary_10_1111_1759_7714_15316
crossref_primary_10_1038_s41420_021_00693_9
crossref_primary_10_1002_mop_32962
crossref_primary_10_1016_j_puhe_2024_01_008
crossref_primary_10_12677_acm_2024_1472054
crossref_primary_10_1111_cbdd_13963
crossref_primary_10_3390_biology10070566
crossref_primary_10_1016_j_apmr_2023_07_005
crossref_primary_10_3389_fonc_2024_1359839
crossref_primary_10_1590_s2237_96222022000300021
crossref_primary_10_1007_s11356_023_29579_2
crossref_primary_10_3389_fpubh_2023_1282451
crossref_primary_10_1186_s13690_022_00918_y
crossref_primary_10_1186_s12966_022_01283_3
crossref_primary_10_1007_s00432_021_03651_1
crossref_primary_10_3389_fepid_2023_1122790
crossref_primary_10_3389_fonc_2021_612009
crossref_primary_10_1038_s41568_020_0266_x
crossref_primary_10_1097_CEJ_0000000000000915
crossref_primary_10_1136_bmjopen_2021_051808
crossref_primary_10_1186_s40164_022_00361_3
crossref_primary_10_3389_fonc_2022_819531
crossref_primary_10_1186_s13550_024_01115_4
crossref_primary_10_7189_jogh_14_04142
crossref_primary_10_1038_s41598_024_65821_8
crossref_primary_10_3389_fonc_2024_1415762
crossref_primary_10_1177_0300060520973137
crossref_primary_10_3390_cancers17020197
crossref_primary_10_1016_j_clbc_2022_02_011
crossref_primary_10_1016_j_rxeng_2021_04_003
crossref_primary_10_1590_1414_462x202533010371
crossref_primary_10_1200_GO_21_00288
crossref_primary_10_1155_2021_9025481
crossref_primary_10_2147_CMAR_S268725
crossref_primary_10_3389_fphys_2023_1042603
crossref_primary_10_1155_2021_6610511
crossref_primary_10_1016_j_ssmph_2023_101418
crossref_primary_10_1155_2022_6168832
crossref_primary_10_3389_fpubh_2021_619581
crossref_primary_10_3390_jcm13071937
crossref_primary_10_1136_bmjopen_2021_050387
crossref_primary_10_1177_10732748221115469
crossref_primary_10_1016_j_injury_2024_111955
crossref_primary_10_1007_s12094_021_02587_9
crossref_primary_10_2147_BCTT_S366530
crossref_primary_10_18632_aging_203472
crossref_primary_10_1111_jog_15931
crossref_primary_10_1097_MD_0000000000023461
crossref_primary_10_3892_etm_2021_9699
crossref_primary_10_1002_cam4_3793
crossref_primary_10_3390_healthcare10091611
crossref_primary_10_1186_s12943_020_1145_5
crossref_primary_10_1016_j_bioorg_2023_106437
crossref_primary_10_18632_aging_203686
crossref_primary_10_3390_ijerph19095399
crossref_primary_10_1016_j_eclinm_2024_103027
crossref_primary_10_1186_s40164_020_00170_6
crossref_primary_10_1002_jcla_23365
crossref_primary_10_3389_fmed_2021_667543
crossref_primary_10_1007_s11356_021_14165_1
crossref_primary_10_1016_j_rx_2021_04_003
crossref_primary_10_1186_s13045_020_00915_0
crossref_primary_10_1080_14737167_2021_1947247
crossref_primary_10_3389_fonc_2021_779185
crossref_primary_10_1186_s12916_024_03772_7
crossref_primary_10_3389_fgene_2020_634195
crossref_primary_10_1177_17588359211009003
crossref_primary_10_1631_jzus_B1900709
crossref_primary_10_1016_j_gaceta_2021_07_011
crossref_primary_10_1016_j_intimp_2020_106797
crossref_primary_10_1002_jcp_29755
crossref_primary_10_1002_cnr2_1827
crossref_primary_10_1136_bmjopen_2022_064417
crossref_primary_10_1007_s11033_020_05823_7
crossref_primary_10_1021_acs_jproteome_1c00075
crossref_primary_10_29333_ejosdr_16054
crossref_primary_10_2147_CMAR_S266575
crossref_primary_10_1016_j_isci_2024_111045
crossref_primary_10_1186_s40164_020_00169_z
crossref_primary_10_1186_s12889_024_18023_w
crossref_primary_10_1016_j_cmet_2021_08_005
crossref_primary_10_12968_ijpn_2023_29_4_159
crossref_primary_10_3390_cancers13122922
crossref_primary_10_1186_s42506_021_00073_2
crossref_primary_10_3389_ijph_2021_603810
crossref_primary_10_1016_j_envint_2021_106725
crossref_primary_10_1259_bjr_20200038
crossref_primary_10_3389_fpubh_2023_1137286
crossref_primary_10_1007_s00432_023_05159_2
crossref_primary_10_1039_D0CC05422D
crossref_primary_10_1007_s10549_022_06543_1
crossref_primary_10_1016_j_senol_2020_12_005
crossref_primary_10_2147_BCTT_S447933
crossref_primary_10_1038_s41746_022_00559_z
crossref_primary_10_1016_j_anr_2023_11_002
crossref_primary_10_1016_j_bioorg_2024_107496
crossref_primary_10_1158_1055_9965_EPI_23_1034
crossref_primary_10_1186_s12890_022_01944_w
crossref_primary_10_3390_healthcare9070907
crossref_primary_10_1016_j_jpba_2021_114134
crossref_primary_10_1007_s12033_022_00524_x
crossref_primary_10_3390_nu15245131
crossref_primary_10_1007_s10815_023_02939_0
crossref_primary_10_1016_j_focha_2023_100453
crossref_primary_10_3389_fonc_2020_00650
crossref_primary_10_1016_j_ecoenv_2022_113551
crossref_primary_10_1016_j_ssmqr_2022_100135
crossref_primary_10_1158_1940_6207_CAPR_20_0369
Cites_doi 10.1093/alcalc/ags011
10.1371/journal.pone.0178928
10.1016/S0140-6736(18)32279-7
10.2991/j.jegh.2018.09.003
10.1186/s13045-019-0799-1
10.1056/NEJMra1707939
10.1001/jamaoncol.2016.5688
10.1016/j.jhep.2015.07.032
10.1016/S0140-6736(16)31392-7
10.1016/S1470-2045(18)30447-9
10.1079/PHN2001294
10.1016/j.breast.2012.08.005
10.1007/s10654-011-9636-8
10.1016/S0140-6736(17)32154-2
10.1023/A:1008953201688
10.3390/cancers10100349
10.1186/1478-7954-10-1
10.1677/ERC-06-0068
10.1001/jamaoncol.2018.2706
10.1016/j.ejca.2018.08.024
10.1097/00001648-199909000-00029
10.1371/journal.pone.0039507
10.1186/s13045-019-0783-9
10.1016/S0140-6736(17)31833-0
10.1200/EDBK_201315
10.1158/1055-9965.1558.13.10
10.1007/978-3-319-09614-8_2
10.2105/AJPH.2012.300913
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s13045-019-0828-0
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
ProQuest Central Health & Medical Collection (via ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ (Directory of Open Access Journals)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ (Directory of Open Access Journals)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-8722
EndPage 12
ExternalDocumentID oai_doaj_org_article_a9a78a15d77e4cc6a866beea415b84c2
PMC6925497
A610324473
31864424
10_1186_s13045_019_0828_0
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom
Western Europe
United States--US
North America
China
India
South Asia
GeographicLocations_xml – name: United Kingdom
– name: Western Europe
– name: South Asia
– name: China
– name: United States--US
– name: North America
– name: India
GrantInformation_xml – fundername: ;
  grantid: No. 81471670
– fundername: ;
  grantid: (2017ZDXM-SF-066
GroupedDBID ---
0R~
2WC
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7T5
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c591t-6c811ebfd6b11e9b69bf0789753effbc72ef577d7d4e28172e19e9f8e9734a4e3
IEDL.DBID M48
ISSN 1756-8722
IngestDate Wed Aug 27 01:27:42 EDT 2025
Thu Aug 21 14:35:47 EDT 2025
Fri Jul 11 11:38:42 EDT 2025
Fri Jul 25 07:52:42 EDT 2025
Tue Jun 17 21:12:50 EDT 2025
Tue Jun 10 20:50:10 EDT 2025
Thu May 22 21:22:21 EDT 2025
Mon Jul 21 06:03:34 EDT 2025
Tue Jul 01 04:23:14 EDT 2025
Thu Apr 24 22:57:24 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Breast cancer
Disability-adjusted life years
Global cancer burden
Alcohol use
Incidence
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c591t-6c811ebfd6b11e9b69bf0789753effbc72ef577d7d4e28172e19e9f8e9734a4e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5209-8626
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13045-019-0828-0
PMID 31864424
PQID 2340760684
PQPubID 54946
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_a9a78a15d77e4cc6a866beea415b84c2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6925497
proquest_miscellaneous_2330062096
proquest_journals_2340760684
gale_infotracmisc_A610324473
gale_infotracacademiconefile_A610324473
gale_healthsolutions_A610324473
pubmed_primary_31864424
crossref_citationtrail_10_1186_s13045_019_0828_0
crossref_primary_10_1186_s13045_019_0828_0
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-12-21
PublicationDateYYYYMMDD 2019-12-21
PublicationDate_xml – month: 12
  year: 2019
  text: 2019-12-21
  day: 21
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of hematology and oncology
PublicationTitleAlternate J Hematol Oncol
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References M Begum (828_CR9) 2018; 104
CJ Murray (828_CR14) 1999; 10
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016 (828_CR12) 2017; 390
Collaboration GBoDC (828_CR3) 2018; 4
BF Hankey (828_CR17) 2000; 11
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017 (828_CR1) 2018; 392
N Mori (828_CR25) 2012; 102
L Vona-Davis (828_CR29) 2007; 14
KJ Foreman (828_CR11) 2012; 10
SH Giordano (828_CR2) 2018; 378
The burden of cancers and their variations across the states of India (828_CR7) 2018; 19
E Cazap (828_CR8) 2018; 38
H Sung (828_CR22) 2019; 69
MJ Hashim (828_CR6) 2018; 8
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016 (828_CR10) 2017; 390
L Lin (828_CR4) 2019; 12
GY Hung (828_CR15) 2015; 63
O Ginsburg (828_CR5) 2017; 389
MJ Lee (828_CR24) 2002; 5
828_CR20
FP Turkoz (828_CR27) 2013; 22
Collaboration GBoDC (828_CR18) 2017; 3
L Zhou (828_CR13) 2019; 12
A Aitsi-Selmi (828_CR26) 2012; 7
S Gao (828_CR16) 2012; 27
HK Seitz (828_CR21) 2012; 47
S Zakhari (828_CR19) 2015; 815
MD Althuis (828_CR28) 2004; 13
Mohd Masood (828_CR23) 2017; 12
References_xml – volume: 47
  start-page: 204
  year: 2012
  ident: 828_CR21
  publication-title: Alcohol and alcoholism (Oxford, Oxfordshire)
  doi: 10.1093/alcalc/ags011
– volume: 12
  start-page: e0178928
  issue: 6
  year: 2017
  ident: 828_CR23
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0178928
– volume: 392
  start-page: 1789
  year: 2018
  ident: 828_CR1
  publication-title: Lancet (London, England)
  doi: 10.1016/S0140-6736(18)32279-7
– volume: 8
  start-page: 54
  year: 2018
  ident: 828_CR6
  publication-title: J Epidemiol Glob Health.
  doi: 10.2991/j.jegh.2018.09.003
– volume: 12
  start-page: 107
  year: 2019
  ident: 828_CR13
  publication-title: Journal of hematology & oncology
  doi: 10.1186/s13045-019-0799-1
– volume: 378
  start-page: 2311
  year: 2018
  ident: 828_CR2
  publication-title: New England Journal of Medicine.
  doi: 10.1056/NEJMra1707939
– volume: 3
  start-page: 524
  year: 2017
  ident: 828_CR18
  publication-title: JAMA oncology.
  doi: 10.1001/jamaoncol.2016.5688
– volume: 63
  start-page: 1390
  year: 2015
  ident: 828_CR15
  publication-title: Journal of hepatology.
  doi: 10.1016/j.jhep.2015.07.032
– volume: 389
  start-page: 847
  year: 2017
  ident: 828_CR5
  publication-title: Lancet (London, England)
  doi: 10.1016/S0140-6736(16)31392-7
– volume: 19
  start-page: 1289
  year: 2018
  ident: 828_CR7
  publication-title: The Lancet. Oncology
  doi: 10.1016/S1470-2045(18)30447-9
– volume: 5
  start-page: 197
  year: 2002
  ident: 828_CR24
  publication-title: Public health nutrition.
  doi: 10.1079/PHN2001294
– volume: 22
  start-page: 344
  year: 2013
  ident: 828_CR27
  publication-title: Breast (Edinburgh, Scotland)
  doi: 10.1016/j.breast.2012.08.005
– volume: 27
  start-page: 39
  year: 2012
  ident: 828_CR16
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-011-9636-8
– volume: 390
  start-page: 1211
  year: 2017
  ident: 828_CR10
  publication-title: Lancet (London, England)
  doi: 10.1016/S0140-6736(17)32154-2
– volume: 11
  start-page: 31
  year: 2000
  ident: 828_CR17
  publication-title: Cancer causes & control : CCC.
  doi: 10.1023/A:1008953201688
– ident: 828_CR20
  doi: 10.3390/cancers10100349
– volume: 69
  start-page: 88
  year: 2019
  ident: 828_CR22
  publication-title: CA: a cancer journal for clinicians
– volume: 10
  start-page: 1
  year: 2012
  ident: 828_CR11
  publication-title: Popul Health Metr
  doi: 10.1186/1478-7954-10-1
– volume: 14
  start-page: 189
  year: 2007
  ident: 828_CR29
  publication-title: Endocrine-related cancer
  doi: 10.1677/ERC-06-0068
– volume: 4
  start-page: 1553
  year: 2018
  ident: 828_CR3
  publication-title: JAMA oncology.
  doi: 10.1001/jamaoncol.2018.2706
– volume: 104
  start-page: 127
  year: 2018
  ident: 828_CR9
  publication-title: European journal of cancer (Oxford, England : 1990)
  doi: 10.1016/j.ejca.2018.08.024
– volume: 10
  start-page: 594
  year: 1999
  ident: 828_CR14
  publication-title: Epidemiology (Cambridge, Mass.)
  doi: 10.1097/00001648-199909000-00029
– volume: 7
  year: 2012
  ident: 828_CR26
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0039507
– volume: 12
  start-page: 96
  year: 2019
  ident: 828_CR4
  publication-title: J Hematol Oncol
  doi: 10.1186/s13045-019-0783-9
– volume: 390
  start-page: 1084
  year: 2017
  ident: 828_CR12
  publication-title: Lancet (London, England)
  doi: 10.1016/S0140-6736(17)31833-0
– volume: 38
  start-page: 451
  year: 2018
  ident: 828_CR8
  publication-title: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
  doi: 10.1200/EDBK_201315
– volume: 13
  start-page: 1558
  year: 2004
  ident: 828_CR28
  publication-title: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  doi: 10.1158/1055-9965.1558.13.10
– volume: 815
  start-page: 7
  year: 2015
  ident: 828_CR19
  publication-title: Advances in experimental medicine and biology
  doi: 10.1007/978-3-319-09614-8_2
– volume: 102
  start-page: 2068
  year: 2012
  ident: 828_CR25
  publication-title: American journal of public health
  doi: 10.2105/AJPH.2012.300913
SSID ssj0061920
Score 2.619355
Snippet Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to estimate...
Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We aimed to...
Abstract Background Statistical data on the incidence, mortality, and burden of breast cancer and the relevant risk factors are valuable for policy-making. We...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 140
SubjectTerms Adolescent
Adult
Age
Age Factors
Aged
Alcohol use
Body mass index
Breast cancer
Breast Neoplasms - etiology
Breast Neoplasms - mortality
Breast Neoplasms, Male - etiology
Breast Neoplasms, Male - mortality
Cancer prevention
Cancer research
Comparative analysis
Confidence intervals
Disabilities
Disability-adjusted life years
Disease
Drinking (Alcoholic beverages)
Fasting
Female
Follow-Up Studies
Gender
Global Burden of Disease
Global cancer burden
Global Health
Glucose
Health risk assessment
Hematology
High income
Humans
Incidence
Male
Middle Aged
Mortality
Oncology
Prevalence
Prognosis
Quality-Adjusted Life Years
Risk assessment
Risk Factors
Studies
Survival Rate
Time Factors
Trends
United Kingdom
Western Europe
Young Adult
SummonAdditionalLinks – databaseName: DOAJ (Directory of Open Access Journals)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yB_Eivm1dNYIgiM12utN5eNtVl0VYTy7sLSSZCi4sPbLTc_AP-TutSnqaaQS9eGqYVJpMqlKPTtVXjL0xFs0QKKhliqqW6DPXwfi-juhah7aJvQ9UKHz-VZ1dyC-X_eVeqy_KCSvwwGXjjrz12njRr7QGGaPyBl8C4NHwBCNj1r5o83bBVNHBFBXs7jCFUUcbQReCGDbbmiDb6mZhhTJY_58qec8mLfMl9wzQ6T12d_Ic-XFZ8X12C4YH7Pb5dDf-kP0q8P085MIEvk48UML5yCMx9ob7YcX9WBpcUb0Up6xyPvXb4VcDF7bnuXUERc-ZfCTYRkIRgc17ToUoSGMbPq45GnT9gWOovr0eN2UIPUk-LeFkXsKncv_DKV3xZ571iF2cfv728ayeujDUsbdirFU0QkBIKxXwaYOyIRFGPcY5kFKIuoXUa73SKwmtQX8IhAWbDFjdSS-he8wOhvUATxk3GB01kSD1Q5IidLYBb2Kfogg66QYq1uy44uIEUU6dMq5dDlWMcoWRDhnpiJGuqdi7ecqPgs_xN-ITYvVMSNDa-QcUODcJnPuXwFXsFQmKK3Wqs4Jwx4qwCaXUXcXeZgpSEbj86KdKB9wEAttaUB4uKPFox-XwThjdpFo2ru0k3aYqIyv2eh6mmZQuN8B6SzQdFcdieFqxJ0V25z-NShx94BZn64VUL3ZlOTJcfc_A48rS5wT97H9s43N2p6XzKNq6FYfsYLzZwgv078bwMh_l34jaTB0
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central Health & Medical Collection (via ProQuest)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9UwEA-6gngRv62uGkEQxLBNm-bDi-yqyyKsJxfeLSRpqgtLu77Xd_Af8u90Js2rW4Q9FZoJpJ3JZCYz8xtC3mgDx1CUkYkuSCbAZmZeu4YFMK19VYbGeSwUPv0mT87E11Wzyhdum5xWudOJSVG3Q8A78oOqFhhEklp8vPzFsGsURldzC42b5BZCl2FKl1rNDhf6BrtIJtfyYMMxLAjOs2EI3MbKxVmUIPv_V8xXTqZl1uSVY-j4Hrmb7Ud6ODH8PrkR-wfk9mmOkD8kfyYQf-pTeQIdOuox7XykAdm7pq5vqRunNldYNUUxt5zmrjv0vKfwgTQ1kEAfOpGPCN6IWCJx855iOQrQmJKOA4VjXX2g4LBvL8bNNAT2JM1LOJqX8HmKAlFMWvydZj0iZ8dfvn86YbkXAwuN4SOTQXMefddKD0_jpfEdItWDtxO7zgdVxa5RqlWtiJUGqyhyE02no1G1cCLWj8leP_TxKaEafKQyILC-7wT3tSmj06HpAveqU2UsSLnjig0ZqBz7ZVzY5LBoaSdGWmCkRUbasiDv5imXE0rHdcRHyOqZEAG204th_cPm_WqdcUo73rRKRRGCdBpkN0YH9o7XIlQFeYWCYqdq1VlN2EOJCIVCqLogbxMFKgpYfnC53gF-AkJuLSj3F5SwwcNyeCeMNiuYjf23HQryeh7GmZg018dhizQ1lsiCk1qQJ5Pszh8Nqhws4Qpmq4VUL_7KcqQ__5ngx6XBSwX17PplPSd3KtxpvGIV3yd743obX4D9NvqXaZP-BWyWQro
  priority: 102
  providerName: ProQuest
Title Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017
URI https://www.ncbi.nlm.nih.gov/pubmed/31864424
https://www.proquest.com/docview/2340760684
https://www.proquest.com/docview/2330062096
https://pubmed.ncbi.nlm.nih.gov/PMC6925497
https://doaj.org/article/a9a78a15d77e4cc6a866beea415b84c2
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rixMxEA_nHRz3RXy7etYIgiCu7iObhyDS6h1HoYeohX4LSZrVg7LVdgveP-Tf6Uz2wS0efvDTQjOBNDOzM7Mz8xtCnksFZshzH7PS8ZiBzxxbaYrYgWtts8QVxmKj8Oycn83ZdFEs9kg33qq9wO21oR3Ok5pvVq9__bx8Dwr_Lii85G-2Kab7IChWMQKyxRDBH4BhEqinM9YnFTBU6BKb1247Iocg4eAgZGxgpQKY_9-v7Cs2a1hPecVAnd4iN1vPko4bUbhN9nx1hxzO2tz5XfK7gfenNjQu0HVJLRak19Qh4zfUVEtq6mYAFvZTUaw6p-08HnpR0VQVNIyWwOg6kNcI64goI377imKjCtCohNZrCgZfvKUQyu9W9bZZAk-TtkeY9Ef42OSHKJYzXoZd98j89OTrh7O4ndIQu0KldcydTFNvyyW38FSWK1sihj3EQb4srROZLwshlmLJfCbBX_Kp8qqUXomcGebz-2S_Wlf-IaESoqfEIeS-LVlqc5V4I11RutSKUiQ-IknHFe1aCHOcpLHSIZSRXDc81cBTjTzVSURe9lt-NPgd_yKeIKt7QoTeDj-sN990q8naKCOkSYulEJ45x40EqfbegCdkJXNZRJ6ioOimj7V_gegxR-xCxkQekReBAoUaju9M2wkBl4BgXAPK4wElqL4bLnfCqDvN0VnOMNvKJYvIs34Zd2I5XeXXO6TJsXkWwteIPGhkt__TnQpERAykenArw5Xq4nsAJucKPzeIR_-98zE5ylAf0yzO0mOyX292_gk4fbUdkRtiIUbkYDyefpnCc3Jy_unzKHxCGQU1_wNn1VgO
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEF_qFdQX8dtotSsoghiaTTbZXUGkZ1uutneItNC3NbvZaKEk9ZJD-g_56N_oTL5sEPrWp4Pb2WMvMzsfmZnfEPJKKjBDLnE-z23ic_CZfSPT2LfgWpswsHFqsFF4vkhmx_zzSXyyRv70vTBYVtnrxEZRZ6XFd-RbYcQxiZRI_vH8p49TozC72o_QaMXiwF38gpCt-rC_A_x9HYZ7u0efZn43VcC3sWK1n1jJmDN5lhj4VCZRJkfMdfDbXZ4bK0KXx0JkIuMulGDfHVNO5dIpEfGUuwh-9wZZ5xGEMhOyPt1dfPna636MRvrcKZPJVsUwEQnhuvIRKs4PRtavGRLwvym4ZAvHdZqXDN_eXXKn81jpditi98iaK-6Tm_MuJ_-A_G7HBlDTNETQMqcGC91ralGgljQtMprW7WAt7NOiWM1Ouzk_9LSgTMW0GVmBUXtDXiNcJKKXuOodxQYYoFEBrUsKjoR4T5euWp3VVbsEHiztjjAdjrDT5p0olkleNLsekuNr4dMjMinKwj0hVEJUFliE8jc5ZyZSgUuljXPLjMhF4DwS9FzRtoNGxwkdZ7oJkWSiW0ZqYKRGRurAI2-HLectLshVxFNk9UCIkN7NF-Xyu-40hE5VKmTK4kwIx61NUgm3xbkUPCwjuQ09somCotv-2EEx6e0EMRE5F5FH3jQUqJrg-DbtOizgISDI14hyY0QJKsWOl3th1J1Kq_S_C-iRl8My7sQyvcKVK6SJsCkXwmKPPG5ld_jTYDzA9w5htxhJ9eipjFeK0x8N4Hmi8DWGeHr1sTbJrdnR_FAf7i8OnpHbId46Fvoh2yCTerlyz8F7rM2L7spS8u26tcRfa8aB5w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+burden+of+breast+cancer+and+attributable+risk+factors+in+195+countries+and+territories%2C+from+1990+to+2017%3A+results+from+the+Global+Burden+of+Disease+Study+2017&rft.jtitle=Journal+of+hematology+and+oncology&rft.au=Li%2C+Na&rft.au=Deng%2C+Yujiao&rft.au=Zhou%2C+Linghui&rft.au=Tian%2C+Tian&rft.date=2019-12-21&rft.pub=BioMed+Central&rft.eissn=1756-8722&rft.volume=12&rft_id=info:doi/10.1186%2Fs13045-019-0828-0&rft_id=info%3Apmid%2F31864424&rft.externalDocID=PMC6925497
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-8722&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-8722&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-8722&client=summon